Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classification

@article{Kim2014MonoclonalAP,
  title={Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classification},
  author={Y. Kim and S. Kim and June-Won Cheong and Yundeok Kim and J. Jang and Jung Yeon Lee and Y. Min and J. Song and W. Yang and J. Kim},
  journal={Annals of Hematology},
  year={2014},
  volume={93},
  pages={1867-1877}
}
  • Y. Kim, S. Kim, +7 authors J. Kim
  • Published 2014
  • Medicine
  • Annals of Hematology
  • Elevated serum free light chain (FLC) is known to be an adverse prognostic factor for diffuse large B-cell lymphoma (DLBCL). We hypothesized that monoclonal gammopathy (MG; elevated kappa [κ] or lambda [λ] FLC with an abnormal κ/λ ratio or a positive IF [immunofixation]) and polyclonal gammopathy (PG; elevated κ and/or λ FLC with a normal κ/λ ratio and a negative IF) would have different clinical outcome according to the molecular classification of DLBCL. In addition, MG would be a poor… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 38 REFERENCES
    Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma
    30
    Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.
    47
    Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms.
    27